Proactive Investors - Run By Investors For Investors

Redx Pharma chief elected to industry body role

From the start of 2019, Lisa Anson will serve as a director of the UK BioIndustry Association for a three-year term
lisa anson
The Redx boss (in a former role as president of the Association of the British Pharmaceutical Industry) said she was "delighted" to be elected to the BIA board

Redx Pharma Plc (LON:REDX) has confirmed its chief executive, Lisa Anson, has been elected to senior industry role.

From the start of 2019, she will serve as a director of the UK BioIndustry Association for a three-year term.

READ: Redx Pharma to focus on progressing oncology and fibrotic drugs in 2019

"I am delighted to be elected to join the BIA Board,” said Anson.

“I am passionate about the UK Biotech sector, as it is not only the focus for much of the exciting science in the UK, but it is also an important sector supporting the UK economy.

“Having previously been president of the Association of the British Pharmaceutical Industry (ABPI), I am personally excited at the prospect of working with the BIA to further the industry."

View full REDX profile View Profile

Redx Pharma Plc Timeline

Related Articles

eye
November 19 2018
“It’s a blended model of highly cash generative assets and top line growth”
skin cream
October 25 2018
The cream is currently undergoing its first-in-human studies, with researchers assessing its skin irritancy, moisturisation potential and skin barrier function
Collagen testing
August 17 2018
Since reporting its full-year results on July 10, the AIM-listed shares have rallied over 38% in the past month to 3.65p currently, taking year-to-date gains to a third

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use